IA-2 and IA-2β: The immune response in IDDM

Diabetes/Metabolism Reviews

Volumn 14, Issue 1, 1998, Pages 85-93

  Notkins, Abner Louis ^a   Lan, Michael S ^b   Leslie, R David G ^c  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b The Research Institute for Children at Children's Hospital New Orleans   (United States)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Autoantibodies; Genes; IA 2; Insulin dependent diabetes mellitus (IDDM); Protein tyrosine phosphatase (PTP)

Indexed keywords

GLUTAMATE DECARBOXYLASE; IA ANTIBODY; IA ANTIGEN; PROTEIN TYROSINE KINASE;

ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; ANTIBODY FORMATION; AUTOANTIBODIES; AUTOANTIGENS; DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS; MEMBRANE PROTEINS; PROTEIN PRECURSORS; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 0031968823     PISSN: 07424221     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0895(199803)14:1<85::AID-DMR205>3.0.CO;2-I     Document Type: Article

References (67)

1. Leslie RDG, and Elliott RB: Early environmental events as a cause of IDDM: Evidence and implications. Diabetes 43: 843-850, 1994.
2. La Porte RE, Matsushima M, and Chang YF: Prevalence and incidence of insulin-dependent diabetes. In Diabetes in America (2nd edn), Harris, MI et al., Eds. NIH Publication No. 95-1468, Bethesda, MD, 1995 pp. 37-46.
3. Foulis AK, and Stewart JA: The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: Insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26: 456-461, 1984.
4. Rossini AA, Handler ES, Mordes JP, and Greiner DL: Human autoimmune diabetes mellitus: Lessons from BB rats and NOD mice - caveat emptor. Clin Immunol Immunopathol 74: 2-9, 1995.
5. Wicker LS, Todd JA, and Peterson LB: Genetic control of diabetes in the NOD mouse. Annu Rev Immunol 13: 179-200, 1995.
6. Tun RYM, Peakman M, Alviggi L, Hussain MJ, Lo SSS, Shattock M, Pyke DA, Bottazzo GF, Vergani D, and Leslie RDG: Importance of persistent cellular and humoral immune changes before diabetes develops: Prospective study of identical twins. Br Med J 308: 1063-1068, 1994.
7. Castano L, Russo E, Zhou L, Lipes MA, and Eisenbarth GS: Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with Type 1 diabetes. J Clin Endocrinol Metab 73: 1197-1201, 1991.
8. Pietropaolo M, Castano L, Babu S, Buelow R, Kuo YL, Martin S, Martin A, Powers AC, Prochazka M, Naggert J, Leiter EH, and Eisenbarth GS: Islet cell autoantigen 69 kD (ICA69): Molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest 92: 359-371, 1993.
9. Rabin DU, Pleasic SM, Shapiro JA, Yoo-Warren H, Oles J, Hicks JM, Goldstein DE, and Rae PM: Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 152: 3183-3188, 1994.
10. Takeda J, Yano H, Eng S, Zeng Y, and Bell GI: A molecular inventory of human pancreatic islets: Sequence analysis of 1000 cDNA clones. Hum Mol Genet 2: 1793-1798, 1993.
11. Tanaka M, Katashima R, Murakami D, Adzuma K, Takahashi Y, Tomonari A, Iwahana H, Yoshimoto K, and Itakura M. Molecular cloning of a group of mouse pancreatic islet beta-cell-related genes by random cDNA sequencing. Diabetologia 38: 381-386, 1995.
12. Goto Y, DeSilva MG, Toscani A, Prabhakar BS, Notkins AL, and Lan MS: A novel human insulinoma-associated cDNA, IA-1, encodes a protein with zinc-finger DNA-binging motifs. J Biol Chem 267: 15252-15257, 1992.
13. Lan MS, Lu J, Goto Y, and Notkins AL: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 13: 505-514, 1994.
14. Krueger NX, Streuli M, and Saito H: Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. EMBO J 9: 3241-3252, 1990.
15. Streuli M, Krueger NX, Thai T, Tang M, and Saito H: Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and LAR. EMBO J 9: 2399-2407, 1990.
16. Lu J, Notkins AL, and Lan MS: Isolation, sequence and expression of a novel mouse brain cDNA, mIA-2, and its relatedness to members of the protein tyrosine phosphatase family. Biochem Biophys Res Commun 204: 930-936, 1994.
17. Passini N, Larigan JD, Genovese S, Appella E, Sinigaglia F, and Rogge L: The 37/40 kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. Proc Natl Acad Sci USA 92: 9412-9416, 1995.
18. Lan MS, Modi WS, Xie H, and Notkins AL: Assignment of IA-2 gene encoding an autoantigen in IDDM to chromosome 2q35. Diabetologia 29: 1001-1003, 1996.
19. Leiter EH, Tsumara H, Serreze DV, Chapman HD, Rabin DU, Lan MS, and Notkins AL: Mapping to chromosome 1 and 12 of mouse homologs of human protein tyrosine phosphatase, receptor-type, related genes encoding pancreatic beta cell autoantigens. Mammalian Genome 8: 949-950, 1997.
20. van den Maagdenberg AM, Olde Weghuis D, Rijss J, van den Wetering RA, Wieringa B, Geurts van Kessel A, and Hendriks WJ: Assignment of the human gene for receptor-type protein tyrosine phosphatase IA-2 (PTPRN) to chromosome region 2q35 → q36.1 and identification of an intragenic genetic marker. Cytogenet Cell Genet 73: 145-148, 1996.
21. Lu J, Li Q, Donadel G, Notkins AL, and Lan MS: Profile and differential expression of protein tyrosine phosphatases in mouse pancreatic islet tumor cell lines. Pancreas (in press).
22. Lu J, Li Q, Xie H, Chen ZJ, Borovitskaya AE, Maclaren NK, Notkins AL, and Lan MS: Identification of a second transmembrane protein tyrosine phosphatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus: Precursor of the 37κDa tryptic fragment. Proc Natl Acad Sci USA 93: 2307-2311, 1996.
23. Li Q, Borovitskaya AE, DeSilva MG, Wasserfall C, Maclaren NK, Notkins AL, and Lan MS: Autoantigens in insulin-dependent diabetes mellitus: Molecular cloning and characterization of human IA-2β. Proc Assoc Am Physicians 109: 429-439, 1997.
24. Wasmeier C, and Hutton JC: Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes. J Biol Chem 271: 18161-18170, 1996.
25. Cui L, Yu WP, DeAizpurua HJ, Schmidli RS, and Pallen CJ: Cloning and characterization of islet cell antigen-related protein-tyrosine phosphatase (PTP), a novel receptor-like PTP and autoantigen in insulin-dependent diabetes. J Biol Chem 271: 24817-24823, 1996.
26. Smith PD, Barker KT, Wang J, Lu YJ, Shipley J, and Crompton MA: ICAAR, a novel member of a new family of transmembrane, tyrosine phosphatase-like proteins. Biochem Biophys Res Commun 229: 402-411, 1996.
27. Fitzgerald LR, Walton KM, Dixon JE, and Largent BL: PTP NE-6: A brain-enriched receptor-type protein tyrosine phosphatase with a divergent catalytic domain. J Neurochem 68: 1820-1829, 1997.
28. Charbonneau H, and Tonks NK: 1002 protein phosphatases? Annu Rev Cell Biol 8: 463-493, 1992.
29. Barford D, Keller JC, Flint AJ, and Tonks NK: Purification and crystallization of the catalytic domain of human protein tyrosine phosphatase 1B expressed in Escherichia coli. J Mol Biol 239: 726-730, 1994.
30. Magistrelli G, Toma S, and Isacchi A: Substitution of two variant residues in the protein tyrosine phosphatase-like PTP35/IA-2 sequence reconstitutes catalytic activity. Biochem Biophys Res Commun 227: 581-588, 1996.
31. Solimena M, Dirkx RJ, Hermel JM, Pleasic-Williams S, Shapiro JA, Caron L, and Rabin DU: ICA 512, an autoantigen of Type 1 diabetes, is an intrinsic membrane protein of neurosecretory granules. EAMBO J 15: 2012-2114, 1996.
32. Xie H, Notkins AL, and Lan MS: IA-2, a transmembrane protein tyrosine phosphatase, is expressed in human lung cancer cell lines with neuroendocrine phenotype. Cancer Res 56: 2742-2744, 1996.
33. Streuli M, Krueger NX, Ariniello PD, Tang M, Munro JM, Blattler WA, Adler DA, Disteche CM, and Saito H: Expression of the receptor-linked protein tyrosine phosphatase LAR: Proteolytic cleavage and shedding of the CAM-like extracellular region. EMBO J 11: 897-907, 1992.
34. Serra-Pages C, Saito H, and Streuli M: Mutational analysis of proprotein processing, subunit association, and shedding of the LAR transmembrane protein tyrosine phosphatase. J Biol Chem 269: 23632-23641, 1994.
35. Jiang YP, Wang H, D'Eustachio P, Musacchio JM, Schlessinger J, and Sap J: Cloning and characterization of R-PTP-kappa, a new member of the receptor protein tyrosine phosphatase family with a proteolytically cleaved cellular adhesion molecule-like extracellular region. Mol Cell Biol 13: 2942-2951, 1993.
36. Brady-Kalnay SM, and Tonks NK: Identification of the homophilic binding site of the receptor protein tyrosine phosphatase PTPu. J Biol Chem 269: 28472-28477, 1994.
37. Lan MS, Wasserfall C, Maclaren NK, and Notkins AL: IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 93: 6367-6370, 1996.
38. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, and Gale EAM: Prediction of IDDM in the general population: Strategies based on combination of autoantibody markers. Diabetes 46: 1701-1710, 1997.
39. Hawa M, Rowe R, Lan MS, Notkins AL, Pozzilli P, Christie MR, and Leslie RDG: Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting Type 1 diabetes. Diabetes 46: 1270-1275, 1997.
40. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, and Eisenbarth GS: Prediction of Type 1 diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bdc/IA-2 autoantibodies. Diabetes 45: 926-933, 1996.
41. Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA, and the DENIS Study Group: Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetologia 39: 1351-1356, 1996.
42. Gorus KF, Goubert P, Semakula C, Vandewalle CL, Schepper JD, Scheen A, Christie MR, and Pipeleers DG: IA-2 autoantibodies complement GAD65 autoantibodies on new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 40: 95-99, 1997.
43. Christie MR, Roll U, Payton MA, Hatfield ECI, and Ziegler AG: Validity of screening for individuals at risk for Type 1 diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care 20: 965-970, 1997.
44. Morales J, Puig-Domingo M, Mauricio D, Piquer S, Vinets I, Lampasona V, Bonifacio E, and de Leiva A: IA2 and GAD 65 antibodies complement islet cell antibodies in IDDM prediction. Diabetologia 39 (Suppl 1): 327, 1996.
45. Genovese S, Bonfanti R, Bazzigaluppi E, Lampasona V, Benazzi E, Bosi E, Chimello G, and Bonifacio E: Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia 39: 1223-1226, 1996.
46. Lohmann T, Seissler J, Verlohren H-J, Schroder S, Rotger J, Dahn K, Morgenthaler N, and Scherbaum WA: Distinct genetic and immunological features in patients with onset of IDDM before and after age 40. Diabetes Care 20: 524-529, 1997.
47. Leslie RDG, and Pozzilli P: Type 1 diabetes masquerading as type II diabetes: Possible implications for prevention and treatment. Diabetes Care 17: 1214-1219, 1994.
48. Niskanen LK, Tuomi T, Karjalainen J, Groop LC, and Uusitupa MIJ: GAD antibodies in NIDDM: Ten year follow up from the diagnosis. Diabetes Care 18; 1557-1565, 1995.
49. Gottsater A, Landin-Olsson M, Fernlund P, Lernmark A, and Sundkvist G: β-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 16: 902-910, 1993.
50. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, and Mackay IR: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of diabetes. Diabetes 42: 359-362, 1993.
51. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, and Holman R: UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350: 1288-1293, 1997.
52. Elbein SC, Wegner K, Miles C, Yu L, and Eisenbarth G: The role of late-onset autoimmune diabetes in white familial NIDDM pedigrees. Diabetes Care 20: 1248-1251, 1997.
53. Christie MR, Vohra G, Champagne P, Daneman D, and Delovitch TL: Distinct antibody specificities to a 64-kD islet cell antigen in Type 1 diabetes as revealed by trypsin treatment. J Exp Med 172; 789-794, 1990.
54. Christie MR, Hollands JA, Brown TJ, Michelsen BK, and Delovitch TL: Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J Clin Invest 92: 240-248, 1993.
55. Christie MR, Tun RYM, Lo SSS, Cassidy D, Brown TJ, Hollands J, Shattock M, Bottazzo GF, and Leslie RDG: Antibodies to GAD and tryptic fragments of islet 64k antigen as distinct markers for development of IDDM: Studies with identical twins. Diabetes 41: 782-787, 1992.
56. Payton MA, Hawkes CJ, and Christie MR: Relationship of the 37,000 and 40,000-M(r) tryptic fragments of islets antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 96: 1506-1511, 1995.
57. Zhang BW, Lan MS, and Notkins AL: Autoantibodies to IA-2 in IDDM: Location of major antigenic determinants. Diabetes 46: 40-43, 1997.
58. Lampasona V, Bearzatto M, Genovese S, Bosi E, Ferrari M, and Bonifacio E: Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen. J Immunol 157: 2707-2711, 1996.
59. Notkins AL, Zhang B, Matsumoto Y, and Lan MS: Comparison of IA-2 and IA-2β and with six other members of the protein tyrosine phosphatase family: Recognition of antigenic determinants by IDDM sera. J Autoimmun 10: 245-250, 1997.
60. Xie H, Zhang B, Matsumoto Y, Li Q, Notkins AL, and Lan MS: Autoantibodies to IA-2 and IA-2β in insulin-dependent diabetes mellitus recognize conformational epitopes: Location of the 37 and 40 kDa fragments determined. J Immunol 159: 3662-3667, 1997.
61. Durinovic-Bellò I, Hummel M, and Ziegler AG: Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 45: 795-800, 1996.
62. Hawa M, Schultz RM, Leslie RDG, Sinigaglia F, Passini N, Rogge L, and Londei M: Cellular markers and inflammatory mediators in IDDM. Diabetologia 40: A83, 1997.
63. Schloot NC, Roep BO, Wegmann D, Yu L, Chase HP, Wang T, and Eisenbarth GS: Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 40: 564-572, 1997.
64. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EAM, and Bottazzo GF: Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335: 147-149, 1990.
65. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, and Camilli PD: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156, 1990.
66. Daniel D, and Wegmann DR: Protection of non-obese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA 93: 956-960, 1996.
67. Tian J, Atkinson MA, Clare-Salzer M, Herschenfeld A, Forsthuber T, Lehmann PV, and Kaufmann DL: Nasal administration of glutamic acid decarboxylase (GAD65) peptides induced Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 183: 1561-1567, 1996.